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Argument for the need of investigation of the relationship
between body fatness and experimental pain sensitivity
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In this communication, we argue about the need for an extensive investigation of the relationship between
body fatness and fat distribution and experimental pain to explore the factors that might contribute to the
increased prevalence of pain conditions in obese individuals.
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O
besityand pain are significant public health pro-
blems and contribute to significant disability world-
wide (1). There appears to be tentative evidence
that individuals with a high body mass index (BMI), which
is often used as a proxy measure of obesity, report higher
pain intensity compared with individuals with normal
BMI (2). However, the relationship between obesity
and pain has received little attention and the potential
mechanisms underlying a putative relationship is not well
understood (3, 4).
Obesity is defined as an increase in body weight as
a result of an excessive accumulation of body fat and
is associated with increased morbidity and mortality
(5). Obesity is commonly measured using the BMI, with
obesity characterised as a BMI greater than 30 kg/m2,
overweight between 25 and 29.9 kg/m2, and normal
weight from 18 to 24.9 kg/m2 (6, 7). The World Health
Organization (2013) reports that more than 1.5 billion
adults worldwide are overweight and approximately
500 million adults meet the criteria for obesity. In the
United States, approximately 78 million adults and 12.5
million children and adolescents are obese (8).
Obesity and chronic pain
Obesity is usually associated with comorbidities (9, 10)
such as diabetes. There is very strong evidence that obesity
is a high-risk factor for elevated cholesterol, heart disease,
type 2 diabetes, cancer, and stroke (10). Obesity may be
influenced by genetic and physiological factors, such as a
thyroid disorder, growth hormone and leptin deficiency,
and lifestyle factors including overeating, especially excess
consumption of sugary and processed foods, and lack of
exercise associated with a sedentary way of life (11).
Obesity is also associated with painful conditions,
including low back pain, fibromyalgia headache, and
osteoarthritis (12). It has been estimated that approxi-
mately 50% of people who are obese regularly experience
pain (13). The International Association of the Study of
Pain (IASP) defines pain as ‘an unpleasant sensory and
emotional experience associated with actual or potential
tissue damage, or described in terms of such damage’
(14). It is unclear whether obesity causes chronic pain or
chronic pain could cause increased weight, or some other
factor(s) cause both conditions concurrently (2, 15). It
has been assumed that pain in obese people could be the
result of the excessive weight, causing mechanical stress to
weight-bearing structures, particularly joints of the back
and lower limbs (16). More recently, attention has been on
the possibility that obesity produces a pro-inflammatory
state and that inflammatory substrates may contribute
to the development of pain (2).
Body fatness and experimental pain
Laboratory investigations into the pain sensitivity re-
sponse of healthy individuals has been used extensively
in pain science to investigate relationships between pain
sensitivity and sex, gender, ethnicity, and other factors that
may influence pain experience. To date, the mechanisms
underlying the supposed relationship between obesity
and an individual’s pain sensitivity response has received
little attention (3, 4, 16, 17). Pain sensitivity is the level at
which an individual reacts to a noxious stimulus and is
measured using controlled experimental stimuli (18).
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Laboratory investigations into the pain sensitivity
response of obese pain-free individuals would be useful
to determine whether obesity contributes to pain experience,
in addition to other factors already known to influence
pain sensitivity response, including age, sex, gender,
ethnicity, and psychological factors such as anxiety and
catastrophising. These factors should be accounted for
in any study of pain sensitivity (19).
The role of pro-inflammatory cytokines
Susceptibility to pain in obese individuals may be affected
by increases in the concentrations of pro-inflammatory
cytokines in the blood (2, 17). Cytokines are proteins
secreted by cells to regulate the immune response to
infection and trauma (17, 20, 21). Some cytokines
promote the healing of wounds; pro-inflammatory cyto-
kines increase inflammation and cause diseases to pro-
gress; anti-inflammatory cytokines suppress the activity of
pro-inflammatory cytokines (20). Inflammatory responses
in the peripheral and central nervous systems play key
roles in the development and persistence of the hallmarks
of pain: redness, swelling, temperature rise, and pain (22).
Cytokines are regulators of adipose tissue metabolism and
are secreted by many cells in the body. Pro-inflammatory
cytokines are predominantly produced by activated macro-
phages and are involved in the up-regulation of inflam-
matory reactions. There is abundant evidence that certain
pro-inflammatory cytokines such as IL-1b, interleukin-6
(IL-6), and tumour necrosis factor-a (TNF-a) are involved
in the process of pathological pain (23). The significance
of cytokines in the development of pain and hyperalgesia
as well as their mechanisms of action on nociceptors has
been realised only during the last decade (24, 25). Adipose
tissue releases inflammatory mediators, including prosta-
glandin, histamine, and interleukin (25). Visceral adipose
tissue in particular is a rich source of pro-inflammatory
cytokines, which appear to be major regulators of adipose
tissue metabolism. There is evidence that obese individuals
have elevated circulation levels of pro-inflammatory cyto-
kines, such as TNF-a, IL-6, and C-reactive protein (CRP).
IL-6 is a circulating cytokine secreted from different types
of cells, including activated macrophages and lympho-
cytes. The biological activity of IL-6 is elevated in the
presence of systemic infection or inflammation (26), and it
is known that IL-6 and TNF-a play key roles in chronic
pain conditions (27).
Obese individuals may be in a pro-inflammatory state
(17). It is unclear whether an increased prevalence of
pain conditions and pain sensitivity in obese individuals
is the result of the inflammatory mediators associated
with adipose tissue or else some other factors, such as
body size and accumulation and distribution of fat, are
also linked to pain sensitivity responses (28).
Conclusion
One way of investigating whether inflammatory mediators
in obese people are associated with pain sensitivity is
to correlate the concentrations of biomarkers of systemic
inflammation in pain-free individuals using experimental
pain induction techniques. However, before undertaking
experimental studies, it is necessary to review the current
status of research literature to contextualise the preva-
lence of chronic pain among obese individuals and the
current understanding of the mechanism by which fat
content of the body affects pain. It is also necessary to
conduct a systematic review of research on experimental
pain sensitivity response and body fatness to determine
the status of current research on the topic and to inform
the design of the experimental studies. Therefore, there is
a need to investigate the relationship between pain sensiti-
vity, body fat distribution, and levels of pro-inflammatory
cytokines. Such a study should be based on an experi-
mental investigation of the relationship between pain
sensitivity, body fat distribution (measured by a state-of-the-
art device), and blood levels of IL-6, CPR, TNF-a, and
leptin.
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